Literature DB >> 12764629

Long-term outcome of hydrocephalus management in myelomeningoceles.

Sagun Tuli1, James Drake, Maria Lamberti-Pasculli.   

Abstract

BACKGROUND: The cerebrospinal fluid (CSF) shunt remains an important ongoing management problem in myelomeningocele (MMC) patients. We reviewed the long-term shunt treatment outcome in a prospectively followed group of MMC patients from a single institution.
METHOD: Patients prospectively entered into a hydrocephalus database with a diagnosis of MMC from the years 1987 to 1996 were selected. All data was verified from the medical records and additional details about the shunt surgery were collected. The outcome of shunt failure was categorized as shunt obstruction, shunt infection, presence of loculated ventricles, overdrainage, and other. All deaths were recorded and causation identified. Univariate analysis for shunt failure risk factors was accomplished using Log rank statistics. Multivariable analysis was performed for each repeated failure level using a conditional Cox regression model.
RESULTS: One hundred and twenty (64%) out of 189 MMC patients experienced a first shunt failure with a median time of 303 days; 29 (24%) of the failures were due to shunt infection (the procedure infection rate being 15%). Sixty-one patients experienced a second shunt failure, 38 a third and 36 had four or more. Multivariable analysis of risk factors failed to demonstrate any clear risk factors for either first or subsequent shunt failure. Fifteen patients died, 13 from either shunt or Chiari 1 complications.
CONCLUSION: Shunt complications remain an important cause of morbidity and mortality in MMC patients, particularly shunt infection.

Entities:  

Mesh:

Year:  2003        PMID: 12764629     DOI: 10.1007/s00381-003-0759-4

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  20 in total

1.  Risk factors for repeated cerebrospinal shunt failures in pediatric patients with hydrocephalus.

Authors:  S Tuli; J Drake; J Lawless; M Wigg; M Lamberti-Pasculli
Journal:  J Neurosurg       Date:  2000-01       Impact factor: 5.115

2.  Comparison of simultaneous versus delayed ventriculoperitoneal shunt insertion in children undergoing myelomeningocele repair.

Authors:  P D Miller; I F Pollack; D Pang; A L Albright
Journal:  J Child Neurol       Date:  1996-09       Impact factor: 1.987

3.  Early repair of myelomeningocele (spina bifida cystica).

Authors:  R F Heimburger
Journal:  J Neurosurg       Date:  1972-11       Impact factor: 5.115

4.  Surgical treatment of myelomeningocele.

Authors:  D D Matson
Journal:  Pediatrics       Date:  1968-08       Impact factor: 7.124

5.  Rationale and methodology of the multicenter pediatric cerebrospinal fluid shunt design trial. Pediatric Hydrocephalus Treatment Evaluation Group.

Authors:  J M Drake; J Kestle
Journal:  Childs Nerv Syst       Date:  1996-08       Impact factor: 1.475

6.  Spina bifida and hydrocephalus.

Authors:  R C Cook
Journal:  Br Med J       Date:  1971-12-25

7.  A search for determinants of cerebrospinal fluid shunt survival: retrospective analysis of a 14-year institutional experience.

Authors:  J H Piatt; C V Carlson
Journal:  Pediatr Neurosurg       Date:  1993 Sep-Oct       Impact factor: 1.162

8.  Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus.

Authors:  J M Drake; J R Kestle; R Milner; G Cinalli; F Boop; J Piatt; S Haines; S J Schiff; D D Cochrane; P Steinbok; N MacNeil
Journal:  Neurosurgery       Date:  1998-08       Impact factor: 4.654

9.  Multiple shunt failures: an analysis of relevant factors.

Authors:  J A Lazareff; W Peacock; L Holly; J Ver Halen; A Wong; C Olmstead
Journal:  Childs Nerv Syst       Date:  1998-06       Impact factor: 1.475

Review 10.  Shunt implantation: reducing the incidence of shunt infection.

Authors:  M Choux; L Genitori; D Lang; G Lena
Journal:  J Neurosurg       Date:  1992-12       Impact factor: 5.115

View more
  16 in total

1.  A retrospective study of infections after primary VP shunt placement in the newborn with myelomeningocele without prophylactic antibiotics.

Authors:  Dorte Clemmensen; Mikkel M Rasmussen; Claus Mosdal
Journal:  Childs Nerv Syst       Date:  2010-03-11       Impact factor: 1.475

2.  Diffusion tensor imaging evaluation of white matter in adolescents with myelomeningocele and Chiari II malformation.

Authors:  Xiawei Ou; Charles M Glasier; Jeffrey H Snow
Journal:  Pediatr Radiol       Date:  2011-07-02

Review 3.  Myelomeningocele: the management of the associated hydrocephalus.

Authors:  G Tamburrini; P Frassanito; K Iakovaki; F Pignotti; C Rendeli; D Murolo; C Di Rocco
Journal:  Childs Nerv Syst       Date:  2013-09-07       Impact factor: 1.475

4.  Rate of shunt revision as a function of age in patients with shunted hydrocephalus due to myelomeningocele.

Authors:  Esther B Dupepe; Betsy Hopson; James M Johnston; Curtis J Rozzelle; W Jerry Oakes; Jeffrey P Blount; Brandon G Rocque
Journal:  Neurosurg Focus       Date:  2016-11       Impact factor: 4.047

5.  External validation of the ETV success score in 313 pediatric patients: a Brazilian single-center study.

Authors:  Leopoldo Mandic Ferreira Furtado; José Aloysio da Costa Val Filho; Eustaquio Claret Dos Santos Júnior
Journal:  Neurosurg Rev       Date:  2021-01-03       Impact factor: 3.042

Review 6.  Hydrocephalus associated with neural tube defects: characteristics, management, and outcome in sub-Saharan Africa.

Authors:  Benjamin C Warf
Journal:  Childs Nerv Syst       Date:  2011-09-17       Impact factor: 1.475

7.  First 60 fetal in-utero myelomeningocele repairs at Saint Louis Fetal Care Institute in the post-MOMS trial era: hydrocephalus treatment outcomes (endoscopic third ventriculostomy versus ventriculo-peritoneal shunt).

Authors:  Samer K Elbabaa; Anne M Gildehaus; Matthew J Pierson; J Andrew Albers; Emanuel J Vlastos
Journal:  Childs Nerv Syst       Date:  2017-05-03       Impact factor: 1.475

8.  Surgical treatment of myelomeningocele: year 2000 hospitalization, outcome, and cost analysis in the US.

Authors:  Anthony H Sin; Mahmoud Rashidi; Gloria Caldito; Anil Nanda
Journal:  Childs Nerv Syst       Date:  2007-06-06       Impact factor: 1.475

9.  Experience in shunt management on revision free survival in infants with myelomeningocele.

Authors:  Sara Al-Hakim; Andreas Schaumann; Joanna Schneider; Matthias Schulz; Ulrich-Wilhelm Thomale
Journal:  Childs Nerv Syst       Date:  2018-03-26       Impact factor: 1.475

10.  Current Management Strategies of Hydrocephalus in the Child With Open Spina Bifida.

Authors:  William Norkett; David G McLone; Robin Bowman
Journal:  Top Spinal Cord Inj Rehabil       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.